Tierra Biosciences Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2015

Location

San Leandro CA US

Primary Industry

Biotechnology

About

Founded in 2015 and based in California, US, Synvitrobio, Inc., dba Tierra Biosciences, operates as a biotechnology platform that develops cell-free manufacturing technology for drug and life sciences discoveries through automated data generation. In March 2024, Tierra Biosciences raised USD 11.4 million in Series A funding led by Material Impact Fund, including Social Capital, Creative Ventures, Freeflow Ventures, Hillspire, In-Q-Tel, and Prosus Ventures. As of 2024, the company is led by its CEO, Michael Nemzek. The company focuses on protein synthesis with its Tierra Protein Platform, which is a solution designed to simplify and accelerate the production of custom proteins. Tierra addresses the challenge of scaling up protein synthesis by leveraging advances in DNA synthesis, sequencing, and de novo protein design. The firm’s platform utilizes machine learning and automation to deliver custom, purified proteins in µg- and mg-scale. The company’s service supports a range of applications, including antibody engineering, drug target synthesis, synthetic biology, and protein optimization. The organization plans to use the March 2024 funding to support developing its artificial intelligence biotechnology platform.

Current Investors

Social Capital, KdT Ventures, Fifty Years

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy

Website

www.tierrabiosciences.com/

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.